| |
|
| |
| Links: |
A Comprehensive research study conducted by KD Market Insights on ” US Intraoperative Neuromonitoring Market by Source Type (Insourced Monitoring and Outsourced Monitoring), Product & Service (System, Accessory, and Service), Application (Spinal Surgery, Neurosurgery, Vascular Surgery, ENT Surgery, Orthopedic Surgery, and Other Surgeries), Modality (Motor Evoked Potential [MEP], Somatosensory Evoked Potential [SSEP], Electroencephalography [EEG], Electromyography [EMG], Brainstem Auditory Evoked Potential [BAEP], and Visual Evoked Potential [VEP]), and End User (Hospital and Ambulatory Surgical Center): U.S. Opportunity Analysis and Industry Forecast, 2014 – 2022 ” report offers extensive and highly detailed historical, current and future market trends in the US and regional/market. The US Intraoperative Neuromonitoring Market report includes market size, growth drivers, barriers, opportunities, trends and other information which helps to find new opportunities in this market for the growth of the business through new technologies and developments.
The U.S. intraoperative neuromonitoring (IONM) market generated $1,239 million in 2015 and is projected to reach $1,938 million by 2022, growing at a CAGR of 6.6% from 2016 to 2022. Intraoperative neurophysiological monitoring (IONM) or intraoperative neuromonitoring is a technique to reduce the risk of neurological deficits after surgical procedures that involve the nervous system. IONM utilizes recordings of electrical potentials from the nervous system during surgical procedures. Neuromonitoring is useful because it offers an opportunity to detect injuries before they become severe. Therefore, with the introduction of IONM, the risk of debilitating deficits, such as muscle weakness, paralysis, hearing loss, and other loss of normal body functions, is reduced.
Request for Sample @ https://www.kdmarketinsights.com/sample/3475
The U.S. IONM market is studied based on product & service, source type, application, modality, end user, and state. Based on product & service, the market is segmented into system, accessory, and service. On the basis of source type, the market is bifurcated into insourced monitoring and outsourced monitoring. As per end user, the market is categorized into hospital and ambulatory surgical center (ASC). IONM finds its application in spinal surgery, neurosurgery, vascular surgery, ENT surgery, orthopedic surgery, and other surgeries related to the central or peripheral nervous system. IONM modalities include motor evoked potential (MEP), somatosensory evoked potential (SSEP), electroencephalography (EEG), electromyography (EMG), brainstem auditory evoked potential (BAEP), and visual evoked potential (VEP). State-wise, the market is analyzed across California, Texas, New York, Florida, Illinois, Colorado, Louisiana, Michigan, Oklahoma, Alaska, Massachusetts, Delaware, Vermont, Connecticut, North Dakota, New Hampshire, Rhode Island, Maine, West Virginia, Pennsylvania, South Dakota, Minnesota, New Jersey, Ohio, Wisconsin, Maryland, Nebraska, Wyoming, Indiana, Montana, Iowa, Missouri, Oregon, Kentucky, Washington, Kansas, Mississippi, Virginia, Arkansas, Tennessee, South Carolina, Hawaii, Alabama, North Carolina, New Mexico, Idaho, Nevada, Georgia, Arizona, and Utah.
Key Benefits for U.S. Intraoperative Neuromonitoring Market :
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all states of the U.S. is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the U.S. market.
U.S. Intraoperative Neuromonitoring Key Market Segments :
By Product & Service
– System
– Accessory
– Service
By Source Type
– Insourced monitoring
– Outsourced monitoring
By Application
– Spinal surgery
– Neurosurgery
– Vascular surgery
– ENT surgery
– Orthopedic surgery
– Other surgery
By Modality
– Motor evoked potential (MEP)
– Somatosensory evoked potential (SSEP)
– Electroencephalography (EEG)
– Electromyography (EMG)
– Brainstem auditory evoked potential (BAEP)
– Visual evoked potential (VEP)
By End User
– Hospital
– Ambulatory surgery center
By State
– California
– Texas
– New York
– Florida
– Illinois
– Colorado
– Louisiana
– Michigan
– Oklahoma
– Alaska
– Massachusetts
– Delaware
– Vermont
– Connecticut
North Dakota
– New Hampshire
– Rhode Island
– Maine
West Virginia
– Pennsylvania
South Dakota
– Minnesota
– New Jersey
– Ohio
– Wisconsin
– Maryland
– Nebraska
– Wyoming
– Indiana
– Montana
– Iowa
– Missouri
– Oregon
– Kentucky
– Washington
– Kansas
– Mississippi
– Virginia
– Arkansas
– Tennessee
South Carolina
– Hawaii
– Alabama
North Carolina
– New Mexico
– Idaho
– Nevada
– Georgia
– Arizona
– Utah
LIST OF KEY PLAYERS PROFILED IN THE REPORT
– Accurate Monitoring, LLC.
– Computational Diagnostics, Inc.
– Intranerve, LLC.
– Inomed Medizintechnik GmbH
– Medtronic Plc
– Moberg Research, Inc. (DAYONE MEDICAL, LLC.)
– Natus Medical Incorporated
– Nihon Kohden Corporation
– Nuvasive, Inc.
– Specialtycare.
Browse Full Report with TOC @ https://www.kdmarketinsights.com/product/intraoperative-neuromonitoring-market-amr
Table of Contents:
Chapter: 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
Chapter: 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.1.1. CXO perspective
Chapter: 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Top player positioning, 2015
3.3. IONM procedures in the U.S., by year
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in prevalence of chronic disorders
3.4.1.2. Surge in U.S. geriatric population
3.4.1.3. Risk management through IONM during complex surgeries
3.4.2. Restraint
3.4.2.1. Additional expenses associated with the insourced monitoring
3.4.3. Opportunity
3.4.3.1. Increase in application of IONM in different surgeries
3.4.4. Impact Analyses
Chapter: 4: U.S. INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Insourced monitoring
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.3. Outsourced monitoring
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
Continue…
Check for Discount @ https://www.kdmarketinsights.com/discount/3475
About Us:
KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights.
Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.
Contact Us:
KD Market Insights
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: sales@kdmarketinsights.com
Website: www.kdmarketinsights.com

The global platelet rich plasma (PRP) market is projected to witness a year-over-year growth rate of 11.8% in 2016 over 2015 to reach US$ 224.0 Mn in revenues. Increase in the number of patients suffering from orthopaedic injuries and widening application area of PRP in different surgeries is likely to catalyse the market the growth. Use of PRP therapy in treating sports injuries is also anticipated to boost the growth of the market.
By type, pure PRP is likely to dominate product segment in 2016 with the revenue share of about 65%. The segment is also forecast to dominate other application segments through the forecast period. This segment is estimated to witness a year-over-year growth of 11.4% to reach US$ 144.3 Mn in revenues in 2016. Pure PRF/Leukocyte rich PRF segment is projected to register impressive year-over-year growth of 15.5% in 2016.
Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1722
By origin, autologous segment will continue to be the prominent segment in 2016, accounting for three fourth of total revenue generated in the year. This segment will witness a year-over-year growth of 11.0% to reach US$ 169.1 Mn in revenues in 2016. Autologous segment among other PRP origins is slated to reflect moderate market performance in 2016, is likely to lose market share to allogenic PRP over next four to five years. Allogenic segment is also projected to register an impressive year-over-year growth of nearly 15% in 2016.
Examining the PRP demand statistics from different surgeries clearly forebodes the dominance of orthopaedic surgery. Currently, orthopaedic surgery is the leading application segment accounting for a revenue share of over 35% in 2016.Orthopaedic surgery is followed by cosmetic surgery, which is estimated to be valued over US$ 50 Mn in 2016. Cosmetic surgery will continue to remain the second-largest application segment, with total revenues expected to reach US$ 59.6 Mn by 2016 end.
In terms of geography, North America, being the advanced market, characterized by early adopters of PRP based therapies. The market in North America is estimated to increase by 11.4% in 2016 to reach very close to US$ 120 Mn. Growth of the market in this region is supported by increasing number of cosmetic and orthopaedic surgeries. Moreover, the region is home to some of the most prominent players operating in the PRP market and hence awareness among patients is also high. Awareness among healthcare community as well as patients is also anticipated to fuel the growth of in North American market.
Adoption of PRP therapy in Asia Pacific is growing at a brisk pace, fuelled by the region’s status as an epicentre of medical tourism. The region has a high geriatric population, and adoption of PRP therapy has witnessed a surge in the recent past. The APAC plasma therapy market is anticipated to increase at a year-on-year growth rate of 16.1% in 2016 to reach US$ 40.5 Mn in revenues.
Request to View Methodology @ https://www.futuremarketinsights.com/askus/rep-gb-1722
Key players operating in the global platelet rich plasma market are Harvest Technologies Corp., Biomet, Inc., Arthrex, Inc. and Arteriocyte Medical Systems, Inc. Dr. PRP America, Cesca Therapeutics, Inc., and Regen Lab SA.
Long-term Outlook: The global platelet rich plasma market is projected to increase at a CAGR of over 12.0% during the forecast period from 2016-2026. North America is forecast to dominate the global market throughout the forecast period, whereas orthopaedic surgery will be the largest application segment
(Added: Tue Apr 02 2019 Hits: 26 Rating: 0.00 Votes: 0) Rate ItPages: [<<] ... 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 ... [>>]
Links SQL By: Gossamer Threads Inc.